MW-108

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMW-108
Drug Alias NameMW01-11-108SRM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of KentuckyNorthwest UniversityColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest UniversityUniversity Of KentuckyColumbia University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A